MARKET

DVA

DVA

DaVita
NYSE

Real-time Quotes | Nasdaq Last Sale

102.13
-0.01
-0.01%
After Hours: 102.14 +0.01 +0.01% 16:31 02/26 EST
OPEN
101.91
PREV CLOSE
102.14
HIGH
103.76
LOW
101.75
VOLUME
845.50K
TURNOVER
--
52 WEEK HIGH
125.28
52 WEEK LOW
62.20
MARKET CAP
11.17B
P/E (TTM)
15.99
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
DaVita Inc. stock outperforms market despite losses on the day
marketwatch.com · 1d ago
Dialysis market is expected to grow at a CAGR of around 5.7% over the forecast period 2019 to 2026
pune, India, Wed, 24 Feb 2021 23:52:09 / Comserve Inc. / -- Acumen Research and Consulting, Recently Published Report on "Dialysis Market Size, Share,...
Comserve · 1d ago
8-K: DAVITA INC.
(EDGAR Online via COMTEX) -- 0000927066false00009270662021-02-242021-02-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 1d ago
BRIEF-Davita Reports Upsize And Pricing Of Add-On Offering Of $1 Bln Senior Notes
reuters.com · 1d ago
DaVita Inc. Announces Upsize and Pricing of Add-On Offering of $1 Billion Senior Notes
DENVER, Feb. 24, 2021 /PRNewswire via COMTEX/ -- DENVER, Feb. 24, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and...
PR Newswire - PRF · 1d ago
DaVita launches add-on offering of $750M senior notes
DaVita (DVA) commenced a private add-on offering of $750M principal amount of its 4.625% senior notes due June 1, 2030.Net proceeds will be used for paying down outstanding borrowings under
Seekingalpha · 2d ago
BRIEF-DaVita Inc Announces Add-On Offering Of $750 Million Senior Notes
reuters.com · 2d ago
Hospitals And Outpatient Care Centers Global Market Report 2021: COVID 19 Impact and Recovery to 2030
New York, Feb 24, 2021 (GLOBE NEWSWIRE via COMTEX) -- New York, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report...
GlobeNewswire · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DVA. Analyze the recent business situations of DaVita through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 11 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DVA stock price target is 120.75 with a high estimate of 150.00 and a low estimate of 99.00.
EPS
Institutional Holdings
Institutions: 796
Institutional Holdings: 123.68M
% Owned: 113.05%
Shares Outstanding: 109.40M
TypeInstitutionsShares
Increased
129
2.58M
New
117
-104.35K
Decreased
224
8.03M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.81%
Healthcare Providers & Services
+0.04%
Key Executives
Chairman/Independent Director
Pamela Arway
Chief Executive Officer/Director
Javier Rodriguez
Chief Financial Officer/Treasurer
Joel Ackerman
Chief Accounting Officer
John Winstel
Chief Compliance Officer
James Hearty
Other
Kenny Gardner
Other
Kathleen Waters
Director
Charles Berg
Director
Shawn Guertin
Independent Director
Barbara Desoer
Independent Director
Paul Diaz
Independent Director
John Nehra
Independent Director
Paula Price
Independent Director
Phyllis Yale
  • Dividends
  • Splits
  • Insider Activity
No Data
About DVA
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Webull offers kinds of Davita Inc stock information, including NYSE:DVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DVA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DVA stock methods without spending real money on the virtual paper trading platform.